Preventive effect of trimetazidine on contrast-induced nephropathy undergoing percutaneous coronary intervention in elderly moderate and high risk diabetics stratified by mehran score.

Zhang, Xue; Zhang, Peng; Yang, Shicheng; Li, Wenyuan; Men, Xiuzhen; Fu, Naikuan

Zhang, Xue; Zhang, Peng; Yang, Shicheng; Li, Wenyuan; Men, Xiuzhen; Fu, Naikuan.

Afiliação

Zhang X; Graduate School of Tianjin Medical University, Tianjin, China.
Zhang P; Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.
Yang S; Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.
Li W; Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.
Men X; Department of Catheter lab, Dongying Second People's Hospital, Shandong,China.
Fu N; Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.

Perfusion ; 36(5): 491-500, 2021 Jul.

Article em En | MEDLINE | ID: mdl-32838661

Assuntos

Diabetes Mellitus; Nefropatias; Intervenção Coronária Percutânea; Trimetazidina; Idoso; Meios de Contraste/efeitos adversos; Angiografia Coronária; Creatinina; Humanos; Intervenção Coronária Percutânea/efeitos adversos; Fatores de Risco; Trimetazidina/uso terapêutico

Palavras-chave

Mehran risk score; contrast-induced nephropathy; diabetics; elderly; trimetazidine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trimetazidina / Diabetes Mellitus / Intervenção Coronária Percutânea / Nefropatias Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google